Stockscreener 앱 받기
1.65
5.71%
-0.10
시간 외 거래:
1.66
0.01
+0.61%
전일 마감가:
$1.75
열려 있는:
$1.765
하루 거래량:
12,696
Relative Volume:
0.08
시가총액:
$11.83M
수익:
$149.50K
순이익/손실:
$-6.96M
주가수익비율:
-0.3466
EPS:
-4.76
순현금흐름:
$-6.37M
1주 성능:
+11.26%
1개월 성능:
+3.77%
6개월 성능:
+18.71%
1년 성능:
-4.07%
1일 변동 폭
$1.65
$1.82
1주일 범위:
$1.48
$1.85
52주 변동 폭
$1.03
$3.6699
Biorestorative Therapies Inc Stock (BRTX) Company Profile
명칭
Biorestorative Therapies Inc
전화
(631) 760-8100
주소
40 MARCUS DRIVE, MELVILLE
Biorestorative Therapies Inc 주식(BRTX)의 최신 뉴스
BioRestorative Therapies (OTCMKTS:BRTXQ) Hits New 1-Year High at $1.50 - MarketBeat
BioRestorative Therapies (OTCMKTS:BRTX) Stock Passes Below 50-Day Moving Average of $1.65 - Defense World
BioRestorative Therapies (NASDAQ:BRTX) Shares Up 1.3% - Defense World
BioRestorative Therapies (OTCMKTS:BRTXQ) Hits New 12-Month High at $1.64 - MarketBeat
BioRestorative Therapies, Inc. (NASDAQ:BRTX) Sees Large Decline in Short Interest - Defense World
BioRestorative Therapies (OTCMKTS:BRTX) Shares Pass Below 50-Day Moving Average of $1.69 - Defense World
BioRestorative Therapies (OTCMKTS:BRTXQ) Sets New 12-Month High at $1.75 - MarketBeat
BioRestorative Therapies, Inc. announced that it has received $0.5 million in funding - Marketscreener.com
BioRestorative Therapies (OTCMKTS:BRTX) Share Price Crosses Below 50 Day Moving Average of $1.70 - Defense World
BioRestorative Therapies, Inc. (NASDAQ:BRTX) Forecasted to Earn Q3 2024 Earnings of ($0.36) Per Share - Defense World
BioRestorative Therapies (NASDAQ:BRTX) PT Raised to $18.00 at Roth Mkm - Defense World
BioRestorative Therapies, Inc. (NASDAQ:BRTX) Q2 2024 Earnings Call Transcript - Insider Monkey
BioRestorative Therapies (NASDAQ:BRTX) Releases Earnings Results, Beats Expectations By $0.06 EPS - Defense World
Roth Capital Equities Analysts Reduce Earnings Estimates for BioRestorative Therapies, Inc. (NASDAQ:BRTX) - Defense World
Roth/MKM raises BioRestorative Therapies stock target on Phase 2 clinical trial - Investing.com India
Roth/MKM raises BioRestorative Therapies stock target on Phase 2 clinical trial - Investing.com
BRTX Stock Earnings: BioRestorative Therapies Beats EPS, Beats Revenue for Q2 2024 - InvestorPlace
BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update - OrthoSpineNews
Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update - StockTitan
BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update - ForexTV.com
BioRestorative Therapies, Inc. (NASDAQ:BRTX) Short Interest Update - Defense World
Head-To-Head Review: BioRestorative Therapies (OTCMKTS:BRTX) vs. Arno Therapeutics (OTCMKTS:ARNI) - Defense World
BioRestorative Therapies (BRTX) to Release Quarterly Earnings on Tuesday - Defense World
BioRestorative Therapies to Report Second Quarter 2024 - GlobeNewswire
BioRestorative Therapies to Report Second Quarter 2024 Financial Results and Host Conference Call on August 13, 2024 - Yahoo Finance
BioRestorative Therapies (OTCMKTS:BRTX) Stock Passes Below 50-Day Moving Average of $1.66 - Defense World
BioRestorative Therapies’ Chief Scientist Named New Section - GlobeNewswire
BioRestorative Therapies’ Chief Scientist Named New Section Editor of the Prestigious Journal of Translational Medicine - StockTitan
BioRestorative Therapies, Inc. (NASDAQ:BRTX) Sees Significant Decline in Short Interest - Defense World
Taking a look at what insiders are doing to gauge the BioRestorative Therapies Inc (BRTX)'s direction – Knox Daily - Knox Daily
Technical analysis of BioRestorative Therapies Inc (BRTX) stock chart patterns – US Post News - US Post News
Analyzing Ratios: BioRestorative Therapies Inc (BRTX)'s Financial Story Unveiled – DWinneX - The Dwinnex
BioRestorative Therapies maintains $15 target on Japan patent news - Investing.com
BioRestorative Therapies maintains $15 target on Japan patent news By Investing.com - Investing.com UK
BioRestorative Therapies Announces Notice of Allowance for - GlobeNewswire
BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem ... - StockTitan
BioRestorative Therapies (OTCMKTS:BRTXQ) Sets New 52-Week High at $2.20 - Defense World
BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program - Yahoo Finance
Investing in BioRestorative Therapies Inc (BRTX): What You Must Know – Knox Daily - Knox Daily
Bullish BioRestorative Therapies, Inc. (NASDAQ:BRTX) insiders filled their treasuries with US$593k worth of stock over ... - Yahoo New Zealand News
Check out these key findings about BioRestorative Therapies Inc (BRTX) – Sete News - SETE News
Market Recap Check: BioRestorative Therapies Inc (BRTX)'s Negative Finish at 2.03, Up/Down -8.56 – DWinneX - The Dwinnex
The Attractiveness of Investing In BioRestorative Therapies Inc (BRTX) is Growing – Knox Daily - Knox Daily
Promising Developments in Waldenstrom Macroglobulinemia Treatment: Mustang Bio's Latest Clinical Trial Results ... - BP Journal
BioRestorative Therapies regains compliance, reports Q1 2024 results - MSN
What's Going On With BioRestorative Therapies Stock? - MSN
BRTXBioRestorative Therapies, Inc. Latest Stock News & Market Updates - StockTitan
What's Going On With BioRestorative Therapies Stock?BioRestorative Therapies (NASDAQ:BRTX) - Benzinga
Q2 2024 EPS Estimates for BioRestorative Therapies, Inc. (NASDAQ:BRTX) Cut by Analyst - Defense World
Biorestorative Therapies Inc (BRTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
1.31%
자본화:
|
볼륨(24시간):